Cargando…
Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts
Bladder cancer (BLCA) is a heterogeneous disease, and there are many classical molecular subtypes that reflect tumor immune microenvironment (TME) heterogeneity but their clinical utility is limited and correct individual treatment and prognosis cannot be predicted based on them. To find reliable an...
Autores principales: | Zhang, Chunyu, Xiao, Jiatong, Yuan, Tong, He, Yunbo, Deng, Dingshan, Xiao, Zicheng, Chen, Jinbo, Zu, Xiongbing, Liu, Peihua, Liu, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184144/ https://www.ncbi.nlm.nih.gov/pubmed/37197406 http://dx.doi.org/10.3389/fphar.2023.1163115 |
Ejemplares similares
-
A glycosylation risk score comprehensively assists the treatment of bladder neoplasm in the real-world cohort, including the tumor microenvironment, molecular and clinical prognosis
por: Liu, Jinhui, et al.
Publicado: (2023) -
An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer
por: Xiao, Zicheng, et al.
Publicado: (2022) -
Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023) -
A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study
por: Li, Huihuang, et al.
Publicado: (2022) -
Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011)